On 11/07/22, an Immediate Jeopardy (IJ) situation was determined to exist related to the facility's failure to ensure the pharmacist conducted a MRR (Medication Regime Review) specific to Warfarin/Coumadin (a blood thinner) and lab monitoring from 03/03/22 to 10/26/22 for Res #63 who received Warfarin. On 11/07/22 at 4:30 p.m., the Oklahoma State Department of Health was notified and verified the existence of the IJ situation. On 11/07/22 at 4:45 p.m., the Regional Manager was notified of the IJ situation. On 11/08/22 at 11:30 a.m., an acceptable plan of removal was submitted to the Oklahoma State Department of Health. The facility's plan of removal, dated 11/07/22, read in part: Plan of Removal Anticoagulant Therapy: Immediate Actions: 1. …
F756 citations in Oklahoma
Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Oklahoma cites F756 more often than its own record predicts
1.02 times the share F756 takes of citations nationally.
Of every deficiency written in Oklahoma in 2025, this is the portion that was F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Oklahoma surveyors wrote
F756 findings written in Oklahoma, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on interview, record review, facility document review, and facility policy review, the facility failed to implement a pharmacy recommendation for discontinuation of an antidepressant medication for 1 (Resident #5) of 5 residents reviewed for unnecessary medications. Specifically, the pharmacist recommended to review Resident #5's sertraline 12.5 milligrams (mg) via peg-tube once daily (QD) for depression. The Medical Director (MD) agreed with the recommendation to discontinue the medication, and the facility failed to follow the order to discontinue it.Findings included: A facility policy titled, Medication Utilization and Prescribing Clinical Protocol, reviewed January 2016, revealed, The Physician, Consultant Pharmacist and staff will adjust existing medications based on their… …
The short window
Recent years
| Year | Share of Oklahoma citations | vs expected |
|---|---|---|
| 2023 | 2.20% | 2.33× |
| 2024 | 1.13% | 1.39× |
| 2025 | 0.80% | 1.02× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Oklahoma surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction